Ads
related to: distributed bragg laser treatment for cancer tumors
Search results
Results From The WOW.Com Content Network
A distributed Bragg reflector laser (DBR) is a type of single frequency laser diode. Other practical types of single frequency laser diodes include DFB lasers and external cavity diode lasers. A fourth type, the cleaved-coupled-cavity laser has not proven to be commercially viable.
Lasers are used to treat cancer in several different ways. Their high-intensity light can be used to shrink or destroy tumors or precancerous growths. Lasers are most commonly used to treat superficial cancers (cancers on the surface of the body or the lining of internal organs) such as basal-cell skin cancer and the very early stages of some cancers, such as cervical, penile, vaginal, vulvar ...
Time-resolved simulation of a pulse reflecting from a Bragg mirror. A distributed Bragg reflector (DBR) is a reflector used in waveguides, such as optical fibers.It is a structure formed from multiple layers of alternating materials with different refractive index, or by periodic variation of some characteristic (such as height) of a dielectric waveguide, resulting in periodic variation in the ...
A distributed-feedback laser (DFB) is a type of laser diode, quantum-cascade laser or optical-fiber laser where the active region of the device contains a periodically structured element or diffraction grating. The structure builds a one-dimensional interference grating (Bragg scattering), and the grating provides optical feedback for the
In medicine, proton therapy, or proton radiotherapy, is a type of particle therapy that uses a beam of protons to irradiate diseased tissue, most often to treat cancer.The chief advantage of proton therapy over other types of external beam radiotherapy is that the dose of protons is deposited over a narrow range of depth; hence in minimal entry, exit, or scattered radiation dose to healthy ...
Experimental cancer treatments are normally available only to people who participate in formal research programs, which are called clinical trials. Occasionally, a seriously ill person may be able to access an experimental drug through an expanded access program. Some of the treatments have regulatory approval for treating other conditions.